tirzepatide march 19th FDA ban on compounded tirzepatide: Switch to name brand medications Lilly's next-gen obesity drug shows

This includes not only removing the mycotoxin burden through mold detox strategies but also stabilizing mast cells and restoring gut-immune homeostasis

BPC-157 shows promise for hair growth primarily through its ability to enhance blood vessel formation and upregulate growth factors like VEGF

TD Cowen analysts estimate retatrutide could generate $3.8 billion in sales by 2030, contributing to a weight-loss drug market projected to reach $100 billion by the 2030s

Glp-1ra and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study

Take back control, quiet cravings, and hush your hunger

Editors Note : On April 4, Rybelsus was approved in Europe for use in the treatment of type 2 diabetes